Anti-p53 Antibody (4F836)

Name: Anti-p53 Antibody (4F836)
Brand: TargetMol
SKU: TMAH-01199
Rating: 4.5 (1 reviews)

还可以

产品编号 TMAH-01199

Anti-p53 Antibody (4F836) 是一种 Mouse 抗体，靶向 p53。Anti-p53 Antibody (4F836) 可用于 ELISA, WB, IHC。

Anti-p53 Antibody (4F836)

还可以

产品编号 TMAH-01199

Anti-p53 Antibody (4F836) 是一种 Mouse 抗体，靶向 p53。Anti-p53 Antibody (4F836) 可用于 ELISA, WB, IHC。

规格	价格	库存	数量
50 μg	¥ 1,305	5日内发货
100 μg	¥ 2,180	5日内发货

大包装 & 定制

加入购物车

TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。

实验操作小课堂

常见问题解答

联系我们获取更多批次信息

资源下载

产品操作手册

产品介绍

生物活性

产品描述	Anti-p53 Antibody (4F836) is a Mouse antibody targeting p53. Anti-p53 Antibody (4F836) can be used in ELISA, WB, IHC.
Ig Type	IgG
克隆号	4F836
交叉反应	Human
验证活性	1. Immunohistochemical of paraffin-embedded Human lung cancer tissue using TMAH-01199 at dilution of 1:200. 2. Immunohistochemical of paraffin-embedded Human rectum cancer tissue using TMAH-01199 at dilution of 1:200. 3. Immunohistochemical of paraffin-embedded Human breast cancer tissue using TMAH-01199 at dilution of 1:200. 4. Western Blot -All lanes:Mouse anti human tumor protein p53 Monoclonal antibody at 1μg/ml -Lane 1:Whole HEK-293 cells Lysates -Secondary Goat polyclonal to Mouse IgG at 1/5000 dilution -Predicted band size:43,38,39,40,34,35,30,24,25KD -Observed band size:53KD
应用	ELISA, WB, IHC
抗体种类	Monoclonal
宿主来源	Mouse
亚细胞定位	Cytoplasm. Nucleus. Nucleus, PML body. Endoplasmic reticulum. Mitochondrion matrix. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome.; [Isoform 1]: Nucleus. Cytoplasm. Note=Predominantly nuclear but localizes to the cytoplasm when expressed with isoform 4.; [Isoform 2]: Nucleus. Cytoplasm. Note=Localized mainly in the nucleus with minor staining in the cytoplasm.; [Isoform 3]: Nucleus. Cytoplasm. Note=Localized in the nucleus in most cells but found in the cytoplasm in some cells.; [Isoform 4]: Nucleus. Cytoplasm. Note=Predominantly nuclear but translocates to the cytoplasm following cell stress.; [Isoform 7]: Nucleus. Cytoplasm. Note=Localized mainly in the nucleus with minor staining in the cytoplasm.; [Isoform 8]: Nucleus. Cytoplasm. Note=Localized in both nucleus and cytoplasm in most cells. In some cells, forms foci in the nucleus that are different from nucleoli.; [Isoform 9]: Cytoplasm.
构建方式	Hybridoma Monoclonal Antibody
纯化方式	Protein G purified
性状	Liquid
缓冲液	Preservative: 0.03% Proclin 300. Constituents: 50% Glycerol, 0.01M PBS, PH 7.4.
纯度	>95%
研究背景	Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2. However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP. In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER2.